Insider · CIK 0001583977

Cormorant Asset Management, LP

CIK 0001583977 Name as filed on the most recent filing

Filed as Cormorant Asset Management, LP (54)· Cormorant Asset Management, LLC (9)

157 transaction lines · from 63 filings · filed 2016-11-07 to 2026-08-10 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

0 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2026-08-10 P, Open-market purchase BlossomHill Therapeutics, Inc.BLSM 5,000,000, acquired Open Form 4 filing 0001231919-26-000852
2026-04-28 S, Open-market sale Bright Minds Biosciences Inc.DRUG 9,785,125, disposed Open Form 4 filing 0000929638-26-001708
2025-12-11 S, Open-market sale Corbus Pharmaceuticals Holdings, Inc.CRBP 344,012, disposed Open Form 4 filing 0000929638-25-004597
2025-12-04 S, Open-market sale EyePoint, Inc.EYPT 942,240, disposed Open Form 4 filing 0000929638-25-004521
2025-09-30 S, Open-market sale MoonLake ImmunotherapeuticsMLTX 40,556, disposed Open Form 4 filing 0000929638-25-003712
2025-09-29 S, Open-market sale MoonLake ImmunotherapeuticsMLTX 4 lines 46,827,628, disposed Open Form 4 filing 0000929638-25-003712
2025-05-15 S, Open-market sale OnKure Therapeutics, Inc.OKUR 3,363,023, disposed Open Form 4 filing 0000929638-25-001950
2025-05-12 S, Open-market sale OnKure Therapeutics, Inc.OKUR 48,236, disposed Open Form 4 filing 0000929638-25-001870
2025-02-14 P, Open-market purchase Aardvark Therapeutics, Inc.AARD 3,000,000, acquired Open Form 4 filing 0000929638-25-000822
2024-11-04 P, Open-market purchase Bright Minds Biosciences Inc.DRUG 3,999,983, acquired Open Form 4 filing 0000929638-24-003752
2024-10-16 P, Open-market purchase Bright Minds Biosciences Inc.DRUG 3 lines 1,172,813, acquired Open Form 4 filing 0000929638-24-003542
2024-10-15 P, Open-market purchase Bright Minds Biosciences Inc.DRUG 8 lines 2,061,574, acquired Open Form 4 filing 0000929638-24-003542
2024-09-27 P, Open-market purchase BioAge Labs, Inc.BIOA 8,100,000, acquired Open Form 4 filing 0000929638-24-003363
2024-09-20 P, Open-market purchase Corbus Pharmaceuticals Holdings, Inc.CRBP 6 lines 7,003,761, acquired Open Form 4 filing 0000929638-24-003217
2024-05-06 P, Open-market purchase EyePoint Pharmaceuticals, Inc.EYPT 2 lines 10,081,721, acquired Open Form 4 filing 0000929638-24-001743
2024-04-18 P, Open-market purchase EyePoint Pharmaceuticals, Inc.EYPT 2 lines 10,489,446, acquired Open Form 4 filing 0000929638-24-001536
2024-04-01 S, Open-market sale Immuneering CorpIMRX 8 lines 1,160,181, disposed Open Form 4 filing 0000929638-24-001336
2024-03-15 S, Open-market sale Immuneering CorpIMRX 856,400, disposed Open Form 4 filing 0000929638-24-001046
2024-03-14 S, Open-market sale Immuneering CorpIMRX 4 lines 1,892,603, disposed Open Form 4 filing 0000929638-24-001046
2024-03-08 P, Open-market purchase Corbus Pharmaceuticals Holdings, Inc.CRBP 7,087,580, acquired Open Form 4 filing 0000929638-24-000985
2024-03-08 P, Open-market purchase Corbus Pharmaceuticals Holdings, Inc.CRBP 2,751,626, acquired Open Form 4 filing 0000929638-24-000985

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.

How to cite this page

ebomi catalog. Cormorant Asset Management, LP, insider transactions. Retrieved 2026-08-23 from https://ebomi.com/insider/0001583977

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.